New award for aspirin 25 MG/dipyridamole 200MG sustained action (SA) capsules with avkare LLC. Base year ordering period is may 14, 2025 - may 13, 2026 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79725D0019
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 73% complete
IDV ceiling
$9,005,168.25
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Avkare LLC on May 14, 2025, with a ceiling of $9,005,168.25 for Aspirin 25 mg/Dipyridamole 200 mg Sustained Action capsules. The contract carries no set-aside. The base ordering period runs May 14, 2025 through May 13, 2026, followed by four one-year options extending through May 2030. Place of performance is Pulaski, Tennessee.

The VA solicited this procurement as an unrestricted, fully competitive acquisition under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The contract supplies capsules to the VA's and Department of Defense's respective Pharmaceutical Prime Vendor Programs, with estimated annual usage of 37,545 bottles of 60-count capsules in cylindrical plastic bottles meeting specified label dimensions. The solicitation, issued in commercial item format in November 2024, sought a responsible offeror capable of providing an uninterrupted source of supply and required submission of the exact drug name and NDC or UPC number.

Avkare LLC is a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, operating as an unrestricted, full-and-open competitor with no small business set-aside status. The contract is part of Avkare's broader portfolio of single-award indefinite-delivery contracts anchored with the VA National Acquisition Center and the Defense Logistics Agency Medical Supply Chain, serving multiple federal healthcare beneficiaries through established pharmaceutical prime vendor programs.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · Modification incorporates section 5 of EO 14398, clause 52.222-90, addressing DEI discrimination $0
Exercise an Option P00002 · Exercise option year one for aspirin 25 MG/dipyridamole 200MG sustained action (SA) capsules with avkare LLC. $0
Add Subcontract Plan P00001 · Incorporate 2026 avkare subcontracting plan for aspirin 25 MG/dipyridamole 200MG sustained action (SA) capsules with avkare LLC. $0
Original award $0

Quick answers

Who was awarded contract 36E79725D0019?

36E79725D0019 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on May 14, 2025.

How much is contract 36E79725D0019 worth?

36E79725D0019's own ceiling is $9,005,168.

Who can order from contract 36E79725D0019?

36E79725D0019 is a single award indefinite delivery contract.

Was contract 36E79725D0019 competed?

The extent of competition for 36E79725D0019 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV